Reimbursement policies in the Asia-Pacific for chronic hepatitis B

被引：0
作者：
Seng Gee Lim
Deepak N. Amarapurkar
Henry Lik-Yuen Chan
Darrell H. Crawford
Edward J. Gane
Kwang-Hyub Han
Sang Hoon Ahn
Wasim Jafri
Jidong Jia
Jia-Horng Kao
Laurentius A. Lesmana
C. Rinaldi A. Lesmana
Rosmawati Mohamed
Pham Hoang Phiet
Teerha Piratvisuth
Shiv K. Sarin
Jose D. Sollarno
Yuichiro Eguchi
Mamun-Al Mahtab
Keat Hong Lee
机构：
[1] National University Health System,Division of Gastroenterology and Hepatology
[2] Bombay Hospital and Medical Research Centre,Department of Gastroenterology and Hepatology
[3] Chinese University of Hong Kong,Department of Medicine and Therapeutics and Institute of Digestive Disease
[4] University of Queensland,School of Medicine
[5] Auckland City Hospital,New Zealand Liver Unit
[6] Yonsei University College of Medicine,Department of Internal Medicine
[7] Aga Khan University,Department of Medicine
[8] Capital Medical University,Liver Research Centre, Beijing Friendship Hospital
[9] National Taiwan University Hospital,Hepatitis Research Centre
[10] University of Indonesia,Department of Internal Medicine, Cipto Mangunkusumo Hospital, Medical Faculty
[11] University of Malaya,Faculty of Medicine
[12] University of Medicine and Pharmacy,Department of Immunology and Physiopathology
[13] Prince of Songkla University,NKC Institute of Gastroenterology and Hepatology
[14] Institute of Liver and Biliary Sciences,Department of Medicine
[15] University of Santo Tomas,Division of Hepatology, Liver Center
[16] Saga Medical School,Department of Hepatology
[17] Bangabandhu Sheikh Mujib Medical University,undefined
来源：
Hepatology International | 2015年 / 9卷
关键词：
Hepatitis B; Reimbursement; Asia Pacific; Antiviral therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：43 / 51
页数：8
相关论文
共 75 条
  • [1] Lavanchy D(2005)Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention J Clin Virol 34 S1-S3
  • [2] Lozano LA(2012)Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010 The Lancet 380 2095-2128
  • [3] Lesmana V(2006)Hepatitis B: overview of the burden of disease in the Asia-Pacific region Liver Int 26 3-10
  • [4] Mahachai PH(2008)The economics of treating chronic hepatitis B in Asia Hepato Int 2 284-295
  • [5] Phiet DJ(2009)Epidemiological serosurvey of hepatitis B in China: declining HBV prevalence due to hepatitis B vaccination Vaccine 27 6550-6557
  • [6] Suh GB(2012)Viral hepatitis in India Clin Lab Med 32 159-174
  • [7] Yao YY(2007)Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease Antivir Ther 12 1295-1303
  • [8] Dan MO(2004)Lamivudine for patients with chronic hepatitis B and advanced liver disease N Engl J Med 351 1521-1531
  • [9] Aung SG(2012)Asia-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update Hepatol Int 6 531-561
  • [10] Lim X(2014)JSG guidelines for the management of hepatitis B virus infection Hepatol Res 44 1-58
12345678